MétaCan
Menu
Back to cohort
Record W1985259133 · doi:10.1016/j.jalz.2013.05.067

IC‐P‐070: Evaluation of a radiolabelled butyrylcholinesterase ligand, N‐methyl‐4‐piperdinyl‐4‐[18F]‐fluorobenzoate, in human brain tissues

2013· article· en· W1985259133 on OpenAlexaff
Courtney Jollymore, Ian R. Macdonald, Ian R. Pottie, Earl Martin, Sultan Darvesh

Bibliographic record

VenueAlzheimer s & Dementia · 2013
Typearticle
Languageen
FieldMedicine
TopicCholinesterase and Neurodegenerative Diseases
Canadian institutionsMount Saint Vincent UniversityDalhousie University
Fundersnot available
KeywordsButyrylcholinesteraseAcetylcholinesteraseNeuropathologyCholinesteraseCholinergicAlzheimer's diseaseAcetylcholineNeurosciencePathologyChemistryDiseaseMedicineInternal medicineAchéPsychologyBiochemistryEnzyme

Abstract

fetched live from OpenAlex

Alzheimer's disease (AD) is a chronic, progressive neurodegenerative disorder of the brain. This disease has characteristic brain hallmarks such as β-amyloid (Aβ) plaques and neurofibrillary tangles (NFTs). Currently, AD pathology is only discernible by post-mortem examination in order to provide definitive disease diagnosis. AD is also characterized by cholinergic dysfunction due to a decrease in the brain levels of the neurotransmitter acetylcholine. The cholinesterases, acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE), regulate levels of this neurotransmitter and in AD these enzymes, especially BuChE, have been found to be associated with Aβ plaques and NFTs. In addition, cholinesterase activity may distinguish Aβ plaques found in AD brain from those present in some cognitively normal individuals. The co-localization of cholinesterase activity with AD pathology may represent a suitable target for diagnosis and treatment monitoring of the disease during life. Currently, positron emission tomography (PET) imaging of Aβ deposits is under consideration for use in AD imaging. However, since Aβ plaques can be observed in some cognitively normal individuals, such imaging appears to be of limited specificity for AD. Co-localization of BuChE with Aβ plaques may be indicative of AD neuropathology thus, fluorine labelled PET imaging agents targeting BuChE could provide a means for non-invasive AD diagnosis during life. N -Methyl-4-piperidinyl-4-fluorobenzoate has been identified, through enzyme kinetics as being specific for BuChE over AChE. Fluorination of a precursor, N-methyl-4-piperdinyl-4-nitrobenzoate, was achieved through nucleophilic aromatic substitution using literature methodology. As such, efforts are underway to further develop 18 F-labelled N -methyl-4-piperdinyl-4-fluorobenzoate to generate in vitro autoradiographs of BuChE in human brain tissues. Comparisons will be made between AD brains and cognitively normal controls displaying Aβ pathology. It is anticipated that the BuChE-specific radioligand will differentiate between AD and non-AD brain tissues. BuChE-specific 18 F imaging agents may differentiate between Aβ plaques in AD and cognitively normal brain tissues. As such, development of cholinesterase-specific 18 F imaging agents should facilitate definitive diagnosis of AD during life.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.000
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Bench or experimental · Consensus signal: Bench or experimental
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.003
Threshold uncertainty score0.006

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0010.000
Meta-epidemiology (narrow)0.0010.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0010.001
Insufficient payload (model declined to judge)0.0020.001

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.054
GPT teacher head0.346
Teacher spread0.292 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designBench or experimental
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2013
Admission routes1
Has abstractyes

Explore more

Same venueAlzheimer s & DementiaSame topicCholinesterase and Neurodegenerative DiseasesFrench-language works237,207